A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma
ConclusionThese results support the novel role of CCK receptors in the pathogenesis of NASH and HCC.
Source: Digestive Diseases and Sciences - Category: Gastroenterology Source Type: research
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Diets | Gastroenterology | Genetics | Hepatocellular Carcinoma | Liver | Liver Cancer | Nutrition | Saturated Fat | Study | Urology & Nephrology